Fundz

Homology Medicines, Inc. reported raising $23.1 Million in an initial SEC Form D filing, from an offering of $23.1 Million

PUBLIC · QTTBJan 06, 2016

Amount Raised

$23.1 Million

$23.1 Million sold, per SEC Form D (first sale Jan 6, 2016)

Round Type

Venture

WalthamBiotechnologyHealthcareHealth CareTherapeutics

Quick answer

Q32 Bio raised $23.1 Million in a funding round, dated January 6, 2016. Q32 Bio is based in Waltham, Massachusetts, United States.

How much did Q32 Bio raise?
Q32 Bio raised $23.1 Million in a funding round on January 6, 2016.
What does Q32 Bio do?
Q32 Bio is a clinical stage biotechnology company whose science targets potent regulators of the adaptive immune system to re-balance immunity and is focused on developing innovative therapies for alopecia areata and..
Where is Q32 Bio based and how big is it?
Q32 Bio is based in Waltham, Massachusetts, United States. Fundz records about 34 employees.
Who are the decision-makers at Q32 Bio?
Fundz holds 1 contact at Q32 Bio, including the Founder and Principal Consultant. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Q32 Bio that raised within 45 days of this round, from Fundz verified event records.

  • Oncotelic Therapeutics raised $300K (Seed) on February 9, 2016.
  • Apellis Pharmaceuticals raised $47M on February 8, 2016.
  • PharmaCyte Biotech, Inc. raised $1M (Seed) on January 19, 2016.
  • Apellis Pharmaceuticals raised $32M on January 6, 2016.
  • IRulya Therapeutics Inc. raised $7.9M on January 5, 2016.
  • Galectin raised an undisclosed amount on December 21, 2015.

Who to call at Q32 Bio, and when

A new round usually means Q32 Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Q32 Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Q32 Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Q32 Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Q32 Bio

Location

Waltham, Massachusetts, United States

About

Q32 Bio is a clinical stage biotechnology company whose science targets potent regulators of the adaptive immune system to re-balance immunity and is focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases. Per the National Alopecia Areata Foundation, about 700,000 people in the United States live with alopecia areata, a disease which has a life-altering impact on patients and limited current treatment options. The Company is advancing bempikibart (ADX-914), a fully human anti-IL-7Rα antibody that re-regulates adaptive immune function, for the treatment of alopecia areata in an ongoing Phase 2 program. The IL-7 and TSLP pathways have been genetically and biologically implicated in driving several T cell-mediated pathological processes in numerous autoimmune diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Q32 Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJoel S., Founder and Principal Consultant hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Q32 Bio's next move

See what Strategic adds

Q32 Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.